Statistics for Iterum Therapeutics plc (id:6128 ITRM)
Valuation metrics
Market cap
48.70M
Enterprise value
40.78M
Trailing P/E (ttm)
3.00
Forward P/E
-2.68
PEG ratio
-2.68
Price/Sales (ttm)
Price/Book (mrq)
-3.03
Enterprise Value/Revenue
Enterprise Value/EBITDA
-1.09
Overview
Shares outstanding
27.52M
Float
21.96M
Shares short
2.53M
% Held by insiders
5.00%
% Held by institutions
5.00%
Average volume (10 days)
1.45M
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
3.02
52-Week change
-10.92%
Beta
2.25
50-Day moving average
1.61
200-Day moving average
1.40
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
August 18, 2022
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-73.35%
Return on equity
599.27%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-37,364,000.00
Net income to common (ttm)
-28,337,000.00
Diluted EPS (ttm)
-1.76
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
11.72M
Total cash per share (mrq)
3.00
Total debt (mrq)
21.62M
Total Debt/Equity (mrq)
-1.88
Current ratio (mrq)
81.60%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-41,950,000.00
Levered free cash flow (LFCF)
-28,464,500.00